Corcept Therapeutics | CORT - Current Liabilities



Corcept Therapeutics reported $144.66M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Acadia Pharmaceuticals USD 330.02M 27.49M Jun/2025
Alaunos Therapeutics USD 4K 822K Oct/2024
ANI Pharmaceuticals USD 236.83M 35.02M Jun/2025
Ardelyx USD 81.72M 3.89M Jun/2025
Aurora Cannabis CAD 156.88M 7.07M Jun/2025
BioMarin Pharmaceutical USD 684.25M 56.03M Jun/2025
Bristol-Myers Squibb USD 27.53B 3.46B Jun/2025
Canopy Growth CAD 98.67M 1.65M Jun/2025
Corcept Therapeutics USD 144.66M 1.6M Jun/2025
Eli Lilly USD 39.02B 8.95B Jun/2025
J&J USD 56.9B 6.58B Mar/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Merck USD 26.04B 863M Jun/2025
Novartis USD 31.71B 95M Jun/2025
Novartis USD 31.71B 3.02B Jun/2025
Pacira USD 313.16M 1.57M Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
Supernus Pharmaceuticals USD 286.36M 4.59M Jun/2025
TG Therapeutics USD 171.89M 11.68M Jun/2025